Home
Home » companies

Chelsea Therapeutics

This Week in Biotech

This Week in Biotech
Motley Fool

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool

This Week in Biotech

This Week in Biotech
Motley Fool

Chelsea's hypotension drug fails to prove efficacy past week one

Chelsea's hypotension drug fails to prove efficacy past week one
Reuters

Chelsea Therapeutics Intl Third Quarter Earnings Sneak Peek

Chelsea Therapeutics Intl Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet

Branham Law, LLP Announces an Investigation of Chelsea Therapeutics International, Ltd. for Possible Securities Law Violations

Branham Law, LLP Announces an Investigation of Chelsea Therapeutics International, Ltd. for Possible Securities Law Violations
Yahoo/BusinessWire

Chelsea Therapeutics Earnings: Loss Narrowed

Chelsea Therapeutics Earnings: Loss Narrowed
Wall St. Cheat Sheet

Chelsea shareholder urges co to explore options

Chelsea shareholder urges co to explore options
Reuters

Chelsea Therapeutics shares sink after FDA recommends additional study for drug candidate

Chelsea Therapeutics shares sink after FDA recommends additional study for drug candidate
Yahoo/AP
Submitted by moderatorj on Mon, 06/25/2012 - 23:14

BioMimetic Therapeutics and Chelsea Therapeutics Recent Performers in a Thriving Industry

BioMimetic Therapeutics and Chelsea Therapeutics Recent Performers in a Thriving Industry
Yahoo/MarketWire